Mapping of low molecular weight heparins using reversed phase ion pair liquid chromatography-mass spectrometry.

Low molecular weight heparins (LMWHs) are structurally complex, highly sulfated and negatively charged, linear carbohydrate polymers prepared by chemical or enzymatic depolymerization of heparin. They are widely used as anticoagulant drugs possessing better bioavailability, longer half-life, and lower side effects than heparin. Comprehensive structure characterization of LMWHs is important for drug quality assurance, generic drug application, and new drug research and development. However, fully characterization of all oligosaccharide chains in LMWHs is not feasible for current available analytical technologies due to their structure complexity and heterogeneity. Fingerprinting profiling is an efficient way for LMWHs' characterization and comparison. In this work, we present a simple, sensitive, and powerful analytical approach for structural characterization of LMWHs. Two different LMWHs, enoxaparin and nadroparin, were analyzed using reversed phase ion pair electrospray ionization mass spectrometry (RPIP-ESI-MS). More than 200 components were identified, including major structures, minor structures, and process related impurities. This approach is robust for high resolution and complementary fingerprinting analysis of LMWHs.

[1]  Jingwu Kang,et al.  Structural analysis of low molecular weight heparin by ultraperformance size exclusion chromatography/time of flight mass spectrometry and capillary zone electrophoresis. , 2013, Analytical chemistry.

[2]  R. Linhardt,et al.  The proteoglycan bikunin has a defined sequence , 2011, Nature chemical biology.

[3]  Peter Roepstorff,et al.  Ion-pairing reversed-phased chromatography/mass spectrometry of heparin. , 2006, Carbohydrate research.

[4]  J. Harenberg Overview on guidelines and recommendations for generic low-molecular-weight heparins. , 2011, Thrombosis research.

[5]  Gary Benson,et al.  GlycReSoft: A Software Package for Automated Recognition of Glycans from LC/MS Data , 2012, PloS one.

[6]  C. Larive,et al.  Reversed-phase ion-pair ultra-high-performance-liquid chromatography-mass spectrometry for fingerprinting low-molecular-weight heparins. , 2013, Journal of chromatography. A.

[7]  R. Linhardt,et al.  Mapping and quantification of the major oligosaccharide components of heparin. , 1988, The Biochemical journal.

[8]  Robert Langer,et al.  Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events , 2008, Nature Biotechnology.

[9]  Z. Shriver,et al.  Sequencing complex polysaccharides. , 1999, Science.

[10]  Weibin Chen,et al.  Analysis of oligosaccharides derived from heparin by ion-pair reversed-phase chromatography/mass spectrometry. , 2009, Analytical chemistry.

[11]  P. Mourier,et al.  Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases. , 2004, Analytical biochemistry.

[12]  G. Jacobson,et al.  Effective reversed-phase ion pair high-performance liquid chromatography method for the separation and characterization of intact low-molecular-weight heparins. , 2009, Analytical biochemistry.

[13]  R. Linhardt,et al.  Synthetic heparin. , 2012, Current opinion in pharmacology.

[14]  E. Hilder,et al.  A simple capillary electrophoresis method for the rapid separation and determination of intact low molecular weight and unfractionated heparins. , 2008, Journal of pharmaceutical and biomedical analysis.

[15]  Robert J Linhardt,et al.  Liquid Chromatography/Mass Spectrometry Sequencing Approach for Highly Sulfated Heparin-derived Oligosaccharides* , 2004, Journal of Biological Chemistry.

[16]  R. Linhardt,et al.  On-line separation and characterization of hyaluronan oligosaccharides derived from radical depolymerization. , 2013, Carbohydrate Polymers.

[17]  R. Linhardt,et al.  Photochemical Preparation of a Novel Low Molecular Weight Heparin. , 2012, Carbohydrate polymers.

[18]  J. Weitz Low-molecular-weight heparins. , 1997, The New England journal of medicine.

[19]  Andre Raw,et al.  Scientific considerations in the review and approval of generic enoxaparin in the United States , 2013, Nature Biotechnology.

[20]  R. Linhardt,et al.  Electrophoresis for the analysis of heparin purity and quality , 2012, Electrophoresis.

[21]  J. Xie,et al.  Structural analysis of bikunin glycosaminoglycan. , 2008, Journal of the American Chemical Society.

[22]  B. Cosmi,et al.  Old and new heparins. , 2012, Thrombosis research.

[23]  Robert J Linhardt,et al.  Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS. , 2012, Analytical Chemistry.